1 Agents affecting nervous system and sensory organs
|
11 Agents affecting central nervous system
|
12 Agents affecting peripheral nervous system
|
13 Agents affecting sensory organs
|
131 Ophthalmic agents
|
1311 Mydriatic agents
|
1312 Miotic agents
|
1313 Ophthalmic local anesthetics
|
1314 Ophthalmic aseptic astringents
|
1315 Ophthalmic cortisones
|
1316 Ophthalmic local vasoconstrictors
|
1317 Ophthalmic antibiotics
|
1318 Alkaloids
|
1319 Others
|
D00983 Triamcinolone acetonide (JP18/USP)
D01121 Rebamipide (JP18/INN)
D00526 Cromolyn sodium (USP); Sodium cromoglicate (JP18)
D00166 Cyanocobalamin (JP18/USP/INN)
D00603 Timolol maleate (JP18/USP)
D00599 Carteolol hydrochloride (JP18/USP)
D00598 Betaxolol hydrochloride (JP18/USP)
D03354 Hyaluronate sodium (USAN); Purified sodium hyaluronate (JP18); Sodium hyaluronate (JAN)
D00222 Acyclovir (USP); Aciclovir (JP18/INN)
D04250 Fradiomycin sulfate and methylprednisolone
D01730 Silver nitrate (JP18/USP)
D00107 Tacrolimus (USP/INN); Tacrolimus hydrate (JP18)
D00904 Diclofenac sodium (JP18/USP)
D02076 Brimonidine tartrate (JAN/USAN)
D00453 Ofloxacin (JP18/USP/INN)
D00210 Norfloxacin (JP18/USP/INN)
D00873 Lomefloxacin hydrochloride (JAN/USAN)
D00588 Levofloxacin (USP); Levofloxacin hydrate (JP18)
D00874 Moxifloxacin hydrochloride (JAN/USP)
D00589 Gatifloxacin (USAN); Gatifloxacin hydrate (JP18)
D01996 Tosufloxacin tosylate hydrate (JP18)
D09574 Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 1] (JAN)
D00184 Cyclosporine (USP); Ciclosporin (JP18)
D04078 Chondroitin sulfate sodium (JAN)
D04114 Neostigmine methylsulfate and inorganic salt
D01717 Levocabastine hydrochloride (JAN/USP)
D01192 Olopatadine hydrochloride (JP18/USP)
D01385 Ibudilast (JP18/INN)
D01332 Ketotifen fumarate (JP18/USAN)
D01713 Epinastine hydrochloride (JAN)
D03243 Sodium borate (JP18/NF)
D01578 Pranoprofen (JP18/INN)
D05143 Nepafenac (JAN/USAN/INN)
D03163 Bromfenac sodium (USAN); Bromfenac sodium hydrate (JP18)
D04246 Fradiomycin sulfate and betamethasone sodium phosphate
D01008 Apraclonidine hydrochloride (JAN/USP)
D00653 Dorzolamide hydrochloride (JP18/USP)
D00652 Brinzolamide (JAN/USP/INN)
D10854 Brinzolamide and brimonidine tartrate
D10512 Brinzolamide and timolol maleate
D01025 Levobunolol hydrochloride (JAN/USP)
D07505 Latanoprost and timolol maleate
D08493 Dorzolamide hydrochloride and timolol maleate (JP18)
D09815 Travoprost and timolol maleate
D10298 Brimonidine tartrate and timolol maleate
D10569 Tafluprost and timolol maleate
D10804 Carteolol and latanoprost
D00356 Latanoprost (JAN/USP/INN)
D01452 Isopropyl unoprostone (JAN)
D02724 Bimatoprost (JAN/USAN/INN)
D01964 Travoprost (JAN/USP/INN)
D06274 Tafluprost (JAN/USAN/INN)
D10966 Omidenepag isopropyl (JAN)
D10463 Ripasudil hydrochloride hydrate (JAN)
D04081 Tropicamide and phenylephrine hydrochloride
D07632 Chondroitin sulfate sodium and sodium hyaluronate
D01162 Verteporfin (JAN/USP/INN)
D05697 Ranibizumab (USAN/INN); Ranibizumab (genetical recombination) (JAN); Ranibizumab (genetical recombination) [Ranibizumab biosimilar 1] (JAN)
D11083 Brolucizumab (USAN/INN); Brolucizumab (genetical recombination) (JAN)
D11516 Faricimab (USAN/INN); Faricimab (genetical recombination) (JAN)
D02706 Sodium gualenate hydrate (JAN)
D04113 Boric acid and Inorganic salt
D03635 Cysteamine hydrochloride (JAN/USAN)
D01089 Boric acid (JP18/NF)
D00014 Glutathione (JP18)
D00031 Oxiglutatione (JAN/INN)
D01031 Helenien (JAN); Xantofyl palmitate (INN)
D01088 Pemirolast potassium (JP18/USAN)
D01100 Pirenoxine (JP18/INN)
D01691 Nipradilol (JAN/INN)
D01887 Bunazosin hydrochloride (JP18)
D02027 Tranilast (JP18/USAN/INN)
D03233 Acitazanolast hydrate (JAN)
D03864 Diquafosol tetrasodium (USAN); Diquafosol sodium (JAN)
D04099 Erythromycin lactobionate and colistin sodium methanesulfonate
D04106 Chloramphenicol and colistin sodium methanesulfonate (JP18)
D04109 Glucose and inorganic salt
D04285 Concentrated glycerin and fructose
D07633 Chondroitin sulfate sodium and FAD sodium
D07703 Hydroxyethyl cellulose, boric acid, dibasic sodium phosphate, potassium chloride, sodium chloride and dried sodium carbonate
D07709 Polyvinyl alcohol and iodine
D12437 Ripasudil hydrochloride and brimonidine tartrate
|
132 Otic and nasal agents
|
133 Vertigo agents
|
139 Miscellaneous
|
19 Other agents affecting nervous system and sensory organs
|
|
2 Agents affecting individual organs
|
|
3 Agents affecting metabolism
|
|
4 Agents affecting cellular function
|
|
5 Crude drugs and Chinese medicine formulations
|
|
6 Agents against pathologic organisms and parasites
|
61 Antibiotics
|
62 Chemotherapeutics
|
621 Sulfonamides
|
622 Tuberculosis preparations
|
623 Leprostatics
|
624 Synthetic antibacterials
|
6241 Pyridonecarboxylic acids
|
D00453 Ofloxacin (JP18/USP/INN)
D00186 Ciprofloxacin (JP18/USP/INN)
D02216 Ciprofloxacin hydrochloride (USP); Ciprofloxacin hydrochloride hydrate (JP18)
D00210 Norfloxacin (JP18/USP/INN)
D00873 Lomefloxacin hydrochloride (JAN/USAN)
D00588 Levofloxacin (USP); Levofloxacin hydrate (JP18)
D00874 Moxifloxacin hydrochloride (JAN/USP)
D01144 Prulifloxacin (JAN/INN)
D05382 Pazufloxacin mesilate (JP18)
D02540 Garenoxacin mesylate (USAN); Garenoxacin mesilate hydrate (JAN)
D02475 Sitafloxacin (USAN); Sitafloxacin hydrate (JAN)
D01996 Tosufloxacin tosylate hydrate (JP18)
D10772 Lascufloxacin hydrochloride (JAN)
|
6249 Others
|
625 Antivirals
|
629 Miscellaneous
|
63 Biological preparations
|
64 Parasitics (systemic)
|
69 Other agents against pathogenic organisms and parasites
|
|
7 Agents not mainly for therapeutic purpose
|
|
8 Narcotics
|